Randomised controlled trials and real-life studies: two answers for one question Sergio Harari Eur Respir Rev, 27 (149) 180080; 10.1183/16000617.0080-2018 | |
Bronchiectasis: a case-based approach to investigation and management Martina Contarini, Simon Finch, James D. Chalmers Eur Respir Rev, 27 (149) 180016; 10.1183/16000617.0016-2018 | |
Systematic review of drug effects in humans and models with surfactant-processing disease Dymph Klay, Thijs W. Hoffman, Ankie M. Harmsze, Jan C. Grutters, Coline H.M. van Moorsel Eur Respir Rev, 27 (149) 170135; 10.1183/16000617.0135-2017 | |
Cardiovascular disease and COPD: dangerous liaisons? Klaus F. Rabe, John R. Hurst, Samy Suissa Eur Respir Rev, 27 (149) 180057; 10.1183/16000617.0057-2018 | |
How long is too long? A scoping review of health system delays in lung cancer Ashanya Malalasekera, Sharon Nahm, Prunella L. Blinman, Steven C. Kao, Haryana M. Dhillon, Janette L. Vardy Eur Respir Rev, 27 (149) 180045; 10.1183/16000617.0045-2018 | |
The broad spectrum of lung diseases in primary antibody deficiencies Francesco Cinetto, Riccardo Scarpa, Marcello Rattazzi, Carlo Agostini Eur Respir Rev, 27 (149) 180019; 10.1183/16000617.0019-2018 | |
Noninvasive ventilation in acute respiratory failure: which recipe for success? Raffaele Scala, Lara Pisani Eur Respir Rev, 27 (149) 180029; 10.1183/16000617.0029-2018 | |
Precision medicine in COPD: where are we and where do we need to go? Venkataramana K. Sidhaye, Kristine Nishida, Fernando J. Martinez Eur Respir Rev, 27 (149) 180022; 10.1183/16000617.0022-2018 | |
Pulmonary hypertension associated with neurofibromatosis type 1 Etienne-Marie Jutant, Barbara Girerd, Xavier Jaïs, Laurent Savale, Caroline O'Connell, Frederic Perros, Olivier Sitbon, Marc Humbert, David Montani Eur Respir Rev, 27 (149) 180053; 10.1183/16000617.0053-2018 | |
Cadmium lung adsorption, citrullination and an enhanced risk of COPD David Hutchinson Eur Respir Rev, 27 (149) 180054; 10.1183/16000617.0054-2018 | |